drugset / Trial / NCT00875277

A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products

NCT00875277

Phase 2 Completed 24 enrolled LEO Pharma
RandomizedParallel-groupSingle-blindOther

Summary

The purpose of this trial is to evaluate the anti-psoriatic effect of LEO 29102 cream and its combination with calcipotriol and betamethasone using a psoriasis plaque test method.

Timeline

Start
2009-04
Primary completion
2009-05
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule 50 unknown Topical
Comparator Daivobet Unknown Topical
Subject LEO 29102 Unknown 2.5 unknown Topical
Subject betamethasone dipropionate Small molecule 0.5 unknown Topical

Indications